Abstract
BackgroundAdequate surveillance of HIV drug resistance prevalence is challenged by heterogenous and inadequate data reporting. To address this issue, we recently published reporting guidance documentation for studies of HIV drug...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have